Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

Programmed cell death ligand 1 (PD-L1) is expressed on both select diffuse large B-cell lymphoma (DLBCL) tumor cells and on tumor-infiltrating nonmalignant cells. The programmed cell death 1 (PD-1)/PD-L1 pathway inhibits host antitumor responses; however, little is known about how this pathway funct...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood
Main Authors: Kiyasu, Junichi, Miyoshi, Hiroaki, Hirata, Akie, Arakawa, Fumiko, Ichikawa, Ayako, Niino, Daisuke, Sugita, Yasuo, Yufu, Yuji, Choi, Ilseung, Abe, Yasunobu, Uike, Naokuni, Nagafuji, Koji, Okamura, Takashi, Akashi, Koichi, Takayanagi, Ryoichi, Shiratsuchi, Motoaki, Ohshima, Koichi
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2015
נושאים:
Lymphoid Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635115/
https://ncbi.nlm.nih.gov/pubmed/26239088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-02-629600
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים